Member Info for bignose58

And closed at 0.144hkd !!!

0.148hkd as I write. This is becoming ridiculous and could certainly could point to something more unfavorable happening in the background, otherwise why have we dropped a further 32% from the favorable loan price of 0.215hkd.

That should read as "the gov phase II......". Unfortunately the recent decline has given me a stutter....LOL...LOL......whoops there I go again.

It is now becoming laughable how the company has been driven into the ground by an incompetent CEO. What's was that about returns ng value to shareholders ? Unfortunately everyone approved him being kept on and paid a huge salary as compensation, which is now running at 4.2% of the companies worth. Hopefully once the phase II finishes, we may possibly get those remaining license agreements sorted which could provide the last remaining lifeline.

I see the gov phase III website was updated again yesterday which now indicates a couple of centres being terminated which I understand was done because they had no recruits. Apparently the money is to be better used for the other centre plus a recent increase in budget and are now runnng at full steam ahead.

What happened to that "possible bull run"......or did they mean "possibly a bull with the runs"..... ?

Nigh on 9% drop today. I wonder if there will be an announcement this evening (Asian time) to say more shares will be hitting the market to buy something concrete, if not concrete itself...... LOL

Indeed. Apparently they required a new entity to hold the duplicate MA so They could obtain a CPP for Senstend so Fosun can register it in China.

As to the Name, I was informed sometime ago (and I think I posted as such) that the product may need to be renamed for some territories.

I am still a little confused with the company naming being used. Plethora Pharma Solutions Ltd, which I understand was incorporated in Ireland 11 months ago, which is not the same as Plethora Solutions Holding Ltd.

So,

As I suspected It is really just so data can be “transported” from EMA MAA to the Chinese FDA. Although nothing more was written, it does mean the Chinese must be looking at the data to enable whether a positive outcome/decision regarding testing can be made. Fingers and legs crossed then everybody.... LOL

Morning Guys,

I've just this morning stepped back in from an 8 day trip to Hokkaido in North Japan. Incredible place with much wilderness. They still have many wild brown bears that roam about and each year who invite humans for breakfast, lunch and dinner (fact) - There are so many bears that the numbers have to be controlled by culling. The locals often eat the meat and use their skins for leather goods....... eek.

Anyways, Thanks to POM who brought the following to my attention to:
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/senstend
and
https://www.medscape.com/viewarticle/918810

Nothing to worry about as apparently Senstend is the registered name to be used in China, although I have no idea why it needs to be EMA approved. Could it somehow be related to using the EMA data for the Chinese approval process? I am in the process of trying to get clarification, so watch this space.

Test

Only a year after being registered and having an importation license issued. They are certainly pulling out all the stops on this one ............ Reminds me of the story of the sloth that was mugged by a group of snails. The police asked the sloth if he had seen who did it. He replied, "no, cos it all happened so fast"........ LOL

Maybe, if the timing is right (or even the plan), the 4mill usd payment from China may somehow be used towards the CBD ?

Warrior don,t be a worrier, sorry I just cdnt resist ;-) I’m sure it’s reduced to 39.99 as part of the new Recordati push/ incentive, otherwise they would price themselves out of the market. :)

The.Italian.

I'm hopeful that the company (JM/JG) will not want to make any CBD agreement with the SP at such a low levels due to magnitude of dilution involved. They surely would want at least 0.25 as originally planned. The owner of the 10.6mill buy order surely would be well P'd off if RPG decided to do that now.

Heimdal,

I'm sure they were just trying their luck given the constant downward spiral, but with hardly any sellers, they are now having to buy directly form broker storage who wont be wanting to just give them away. Hopefully you are right about tomorrow. Maybe things are beginning to look up with the oncoming end of phase II in December and projected commencement of phase III in Q1 2020. We still have a product that will corner the market in the US. One just has to look at all the companies currently getting in on the ED circuit with gells, creams and you name it, but there are not that many developing any PE products which leaves only Fortacin (apart from some vibrating device which will only give "white finger"(look it up) or is that white dick....LOL) and one or two substandard OTC products.

One step closer..... ;-)

The FDA gov website https://clinicaltrials.gov/ct2/show/NCT03578783 was updated on the 5th Sept. Now indicating phase II study finish date as 31st Dec 2019 in line with what was announced.

At least some progress even if it was just to switch on the PC and upload the new date...LOL

Heimdal

Thanks for posting. All very interesting indeed.

For an automatic T/O they would have to hold at least 30% of the stock, however. That doesn't mean it will be approved since, and correct me if I am wrong, but don't they then need a 75% majority vote for it to be passed? Unless JM/JG and their followers approve, which I am sure they wont (unless the T/O bid is probably in the region of 300 to 500 mill USD), surely there is no point in trying to pick up a couple of million here and there ?

I am sure you know a lot more about theses things than I do, so I could be just thinking and writing rubbish.... ;-)

If anyone is interested:

http://www.businesskorea.co.kr/news/articleView.html?idxno=33973